<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-9J99E681</identifier><date>2024</date><creator>Borštnar, Simona</creator><creator>Grašič-Kuhar, Cvetka</creator><creator>Privšek, Nina</creator><relation>documents/doc/9/URN_NBN_SI_doc-9J99E681_001.pdf</relation><relation>documents/doc/9/URN_NBN_SI_doc-9J99E681_001.txt</relation><format format_type="issue">2</format><format format_type="volume">28</format><format format_type="type">article</format><format format_type="extent">str. 30-39</format><identifier identifier_type="DOI">10.25670/oi2024-015on</identifier><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">224003843</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-9J99E681</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">HER2</subject><subject language_type_id="slv">rak dojk</subject><subject language_type_id="slv">trastuzumab derukstekan</subject><title>Učinkovitost in varnost zdravljenja s trastuzumab derukstekanom</title><title>analiza podatkov iz realnega sveta</title><title>Efficacy and safety of trastuzumab deruxtecan therapy</title><title>analysis of real-world data</title></Record>